Showing 1851-1860 of 6037 results for "".
- Centre for Sight Launches 'Eye Health MOT' to Support Early Detection and Long-Term Vision Carehttps://modernod.com/news/centre-for-sight-launches-eye-health-mot-to-support-early-detection-and-long-term-vision-care/2485486/Centre for Sight has launched a new 'Eye Health MOT' service for people aged 40 and over, designed to offer a comprehensive, consultant-led assessment to detect early signs of eye disease before symptoms appear. According to C
- OneSight EssilorLuxottica Foundation and Vision To Learn Extend Partnership to Expand Vision Care for Children Nationwidehttps://modernod.com/news/onesight-essilorluxottica-foundation-and-vision-to-learn-extend-partnership-to-expand-vision-care-for-children-nationwide/2484209/The OneSight EssilorLuxottica Foundation and Vision To Learn announced a 2-year extension of their 8-year partnership dedicated to providing vision care services to children in need—helping them see clearly and reach their full potential in school and be
- GATHER2 Study Shows Izervay Monthly or Every Other Month Reduced GA Lesion Growth Through 2 Yearshttps://modernod.com/news/gather2-study-shows-izervay-monthly-or-every-other-month-reduced-ga-lesion-growth-through-2-years/2481944/Astellas Pharma announced results from the GATHER2 phase 3 clinical trial, demonstrating Izervay (avacincaptad pegol intravitreal solution) continued to reduce the rate of geographic atrophy (GA) lesion growth for both every month (EM) and every-other-month (EOM) dosing vs. sham through
- FCI Ophthalmics Announces Availability of EzyPor Polyethylene Orbital Implanthttps://modernod.com/news/fci-ophthalmics-announces-availability-of-ezypor-polyethylene-orbital-implant/2481336/FCI Ophthalmics announced the launch of EzyPor in the United States. EzyPor is a high density polyethylene orbital implant with a patented suturing platform, indicated for enucleation, evisceration, and secondary implantation. Ezyor is designed to have a smooth
- FDA Accepting Less Data, More Surrogate Endpoints in Trialshttps://modernod.com/news/fda-accepting-less-data-more-surrogate-endpoints-in-trials/2477241/Over the last four decades, the FDA has loosened its requirements for approving new drugs, increasingly accepting less data and more surrogate endpoints in clinical trials, and shortening its reviews, according to a new analysis, as reported</
- 2020 World Ophthalmology Congress Cancelled; Virtual Program Plannedhttps://modernod.com/news/2020-world-ophthalmology-congress-cancelled-virtual-program-planned/2479534/Due to the COVID-19 pandemic, The International Council of Ophthalmology (ICO) has decided to cancel the World Ophthalmology Congress (WOC2020), scheduled to take place June 26-29, in Cape Town, Africa. In a message to its members, ICO leadership stated that it remains devoted to bringing
- Ellex to Host an AMD Roundtable During AAO 2018https://modernod.com/news/ellex-to-host-an-amd-roundtable-during-aao-2018/2479760/Ellex Medical Lasers Limited announced that it will partner with a panel of leading ophthalmologists to host a roundtable on age-related macular degeneration (AMD) on Friday, October 26, during the American Academy of Ophthalmology (AAO) meeting in Chicago. “Our goal is to start a serious
- Vision Innovation Partners Announces Suspension of Most Office Services, Warby Parker Informs Customers of Store Closures for Two Weeks Due to Coronavirushttps://modernod.com/news/vision-innovation-partners-announces-suspension-of-most-office-services-warby-parker-informs-customers-of-store-closures-for-two-weeks-due-to-coronavirus/2477399/Two vision care businesses are among the first groups in the U.S. to announce that they will be instituting closures of their offices and store networks to prevent the spread of the coronavirus (COVID-19), according to a VisionMonday
- Vision Integrated Partners Completes Refinancinghttps://modernod.com/news/vision-integrated-partners-completes-refinancing/2482123/Vision Integrated Partners (VIP) has successfully completed a recapitalization that consist of $25 million revolving credit facility, a $155 million term loan, and a $12.5 million delayed draw term loan. Proceeds from the credit facilities will be used to refinance existing indebte
- Rayner Establishes Direct Presence in Francehttps://modernod.com/news/rayner-establishes-direct-presence-in-france/2480956/Rayner announced its direct entry into the French cataract and refractive market. Based out of Lille in the Hauts-de-France region, Rayner has a growing team of ophthalmic specialist area managers focussed on delivering service and support. Through this team, French ophthalmologist